South Africa has become the first African country, and our medicines regulator the third worldwide, to register the revolutionary twice-a-year anti-HIV jab lenacapavir (LEN) that could bring an end to HIV/Aids if enough people take it. For more on this, I am joined on the line by…
GUEST: Mia Malan, Founder and Editor-in-Chief of Bhekisisa

Tech Talk: GRIT App
07:48

CRL Rights Commission address challenges impacting the initiation practice and launch investigative mechanism
09:56

WINNING/CHAMPION’ From intern to curator: Annerie Senekal becomes first female to lead Stellenbosch University Botanical Garden.
06:50